Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nanji

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The British Journal of Surgery|May 26, 2017
Population-based study to re-evaluate optimal lymph node yield in colonic cancerJ C Del Paggio, Y Peng, X Wei, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 5, 2020
Effectiveness of Trastuzumab in Routine Clinical Practice: A Population-based Study of Patients with HER-2-positive Oesophageal, Gastroesophageal and Gastric CancerS J Merchant, W Kong, B Gyawali, et al.
Cytogenetics and Cell Genetics|July 28, 2001
Characterization and chromosomal localization of five canine ATOX1 pseudogenesB van de Sluis, M S Nanji, M Breen, et al.
American Journal of Human Genetics|June 1, 1997
Haplotype and mutation analysis in Japanese patients with Wilson diseaseM S Nanji, V T Nguyen, J H Kawasoe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 25, 2016
Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General PopulationC M Booth, S Nanji, X Wei, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 17, 2000
Assessment of patient waiting times for vascular surgeryR G Turnbull, D C Taylor, Y N Hsiang, et al.
Leukemia|May 23, 2001
Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 studyS Trudel, Z Li, C Dodgson, et al.
Journal of Hematotherapy & Stem Cell Research|May 3, 2000
Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugsF Omori, T Juopperi, C K Chan, et al.
Human Gene Therapy|August 31, 1999
Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow culturesA K Stewart, D R Sutherland, S Nanji, et al.
Seminars in Oncology|November 24, 1999
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphomaR Buckstein, K Imrie, D Spaner, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The British Journal of Surgery|May 26, 2017
Population-based study to re-evaluate optimal lymph node yield in colonic cancerJ C Del Paggio, Y Peng, X Wei, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 5, 2020
Effectiveness of Trastuzumab in Routine Clinical Practice: A Population-based Study of Patients with HER-2-positive Oesophageal, Gastroesophageal and Gastric CancerS J Merchant, W Kong, B Gyawali, et al.
Cytogenetics and Cell Genetics|July 28, 2001
Characterization and chromosomal localization of five canine ATOX1 pseudogenesB van de Sluis, M S Nanji, M Breen, et al.
American Journal of Human Genetics|June 1, 1997
Haplotype and mutation analysis in Japanese patients with Wilson diseaseM S Nanji, V T Nguyen, J H Kawasoe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 25, 2016
Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General PopulationC M Booth, S Nanji, X Wei, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 17, 2000
Assessment of patient waiting times for vascular surgeryR G Turnbull, D C Taylor, Y N Hsiang, et al.
Leukemia|May 23, 2001
Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 studyS Trudel, Z Li, C Dodgson, et al.
Journal of Hematotherapy & Stem Cell Research|May 3, 2000
Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugsF Omori, T Juopperi, C K Chan, et al.
Human Gene Therapy|August 31, 1999
Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow culturesA K Stewart, D R Sutherland, S Nanji, et al.
Seminars in Oncology|November 24, 1999
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphomaR Buckstein, K Imrie, D Spaner, et al.
Pageof 3